Evidence map›Paper›PMID 42543427›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Comparison of two classification systems for tissue eosinophilia in patients with chronic rhinosinusitis with nasal polyps.

Xiangmin Zhou, Qian Zhang, Jinfeng Luo, Tao Li, Chuanping Liu, Yuzhu Wan, Li Shi

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiangmin Zhou *Department of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China.
Qian Zhang *Department of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China.
Jinfeng LuoDepartment of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China.
Tao LiDepartment of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China.
Chuanping LiuDepartment of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China.
Yuzhu WanDepartment of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China. wanyuzhu001@126.com.ORCID http://orcid.org/0000-0001-6184-5902
Li ShiDepartment of Rhinology, Shandong Provincial ENT Hospital, Shandong University, Jinan, 250000, Shandong, China. shili126@sina.com.

Funding

National Natural Science Foundation of China 82371117Natural Science Foundation of Shandong Province ZR2024QH420
6 · The paper itself

Abstract

backgroundEosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) is commonly defined by absolute tissue eosinophil count (≥ 10 per high-power field; Def1) or eosinophil percentage of total inflammatory cells (≥ 10% per high-power field; Def2). However, these two criteria sometimes yield discordant classifications, and no consensus exists on an appropriate range of total inflammatory cells for consistent diagnosis. This study compared the consistency of these two definitions and explored whether a specific range of total inflammatory cell counts could improve their diagnostic agreement.

methodsNasal polyp tissues from 104 patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and inferior turbinate samples from 19 healthy controls were analyzed. Tissue eosinophil count, eosinophil percentage, and total inflammatory cell counts were assessed histologically. Receiver operating characteristic analysis, correlation analysis, positive and negative predictive values (PPVs and NPVs), peripheral blood eosinophil indices, and local type 2 cytokine expression (IL-4, IL-5, and IL-13) were used to explore and internally assess the proposed interval.

resultsDef1 and Def2 were concordant in 88 of 104 patients, with discrepancies mainly observed outside the proposed 385-1236 total inflammatory cell-count interval. Within this interval, the correlation between tissue eosinophil count and percentage was stronger (r = 0.93), and PPVs and NPVs for ECRSwNP classification were higher (PPV: 100.00%/91.89%; NPV: 89.29%/100.00%). Peripheral blood eosinophil indices and IL-4, IL-5, and IL-13 expression also showed stronger associations with eosinophil-based classification within this interval than outside it.

conclusionWe identified an exploratory total inflammatory cell-count interval of 385-1236, within which Def1 and Def2 showed more consistent classification of ECRSwNP in the present cohort.

Indexed as

EosinophiliaEosinophilsNasal PolypsRhinitisRhinosinusitisSinusitisAdultAgedChronic DiseaseFemaleHumansLeukocyte CountMaleMiddle AgedROC CurveYoung AdultCRSwNPDiagnostic criteriaECRSwNPEosinophil countEosinophil percentage

Identifiers

PMID42543427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.